Abstract
Patients younger than 55 years with degenerative conditions of the glenohumeral joint represent a unique population that can be treated with shoulder arthroplasty. Certain challenges related to this cohort may include greater patient expectations, higher functional demands, soft-tissue contracture from previous surgery, and glenoid bone loss. Surgical treatment options include unconstrained total shoulder arthroplasty; hemiarthroplasty; humeral head resurfacing alone; hemiarthroplasty with concentric reaming of the glenoid; and hemiarthroplasty with adjunctive biologic glenoid resurfacing with autogenous fascia lata, Achilles tendon allograft, or meniscal allograft.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 99-104 |
| Number of pages | 6 |
| Journal | Instructional course lectures |
| Volume | 60 |
| State | Published - 2011 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Shoulder arthroplasty for the young, active patient. / Tibbetts, Ryan M.; Wirth, Michael A.
In: Instructional course lectures, Vol. 60, 2011, p. 99-104.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Shoulder arthroplasty for the young, active patient.
AU - Tibbetts, Ryan M.
AU - Wirth, Michael A
PY - 2011
Y1 - 2011
N2 - Patients younger than 55 years with degenerative conditions of the glenohumeral joint represent a unique population that can be treated with shoulder arthroplasty. Certain challenges related to this cohort may include greater patient expectations, higher functional demands, soft-tissue contracture from previous surgery, and glenoid bone loss. Surgical treatment options include unconstrained total shoulder arthroplasty; hemiarthroplasty; humeral head resurfacing alone; hemiarthroplasty with concentric reaming of the glenoid; and hemiarthroplasty with adjunctive biologic glenoid resurfacing with autogenous fascia lata, Achilles tendon allograft, or meniscal allograft.
AB - Patients younger than 55 years with degenerative conditions of the glenohumeral joint represent a unique population that can be treated with shoulder arthroplasty. Certain challenges related to this cohort may include greater patient expectations, higher functional demands, soft-tissue contracture from previous surgery, and glenoid bone loss. Surgical treatment options include unconstrained total shoulder arthroplasty; hemiarthroplasty; humeral head resurfacing alone; hemiarthroplasty with concentric reaming of the glenoid; and hemiarthroplasty with adjunctive biologic glenoid resurfacing with autogenous fascia lata, Achilles tendon allograft, or meniscal allograft.
UR - http://www.scopus.com/inward/record.url?scp=84879157736&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879157736&partnerID=8YFLogxK
M3 - Article
C2 - 21553765
AN - SCOPUS:84879157736
VL - 60
SP - 99
EP - 104
JO - Instructional course lectures
JF - Instructional course lectures
SN - 0065-6895
ER -